Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Monopar Therapeutics (MNPR) Shares Outstanding (2016 - 2020)

Monopar Therapeutics (MNPR) has disclosed Shares Outstanding for 5 consecutive years, with $11.5 million as the latest value for Q3 2020.

  • Quarterly Shares Outstanding rose 23.26% to $11.5 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $11.5 million through Sep 2020, up 23.26% year-over-year, with the annual reading at $10.6 million for FY2019, 13.95% up from the prior year.
  • Shares Outstanding hit $11.5 million in Q3 2020 for Monopar Therapeutics, up from $10.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $11.5 million in Q3 2020 to a low of $9.3 million in Q4 2017.
  • Historically, Shares Outstanding has averaged $9.8 million across 4 years, with a median of $9.3 million in 2017.
  • Biggest five-year swings in Shares Outstanding: soared 7917.17% in 2017 and later changed 0.0% in 2018.
  • Year by year, Shares Outstanding stood at $115894.0 in 2016, then skyrocketed by 7917.17% to $9.3 million in 2017, then changed by 0.0% to $9.3 million in 2018, then grew by 13.95% to $10.6 million in 2019, then rose by 8.17% to $11.5 million in 2020.
  • Business Quant data shows Shares Outstanding for MNPR at $11.5 million in Q3 2020, $10.7 million in Q2 2020, and $10.6 million in Q1 2020.